The increased prevalence of atopic diseases, atopic dermatitis, allergic rhinitis, and asthma has been described as an epidemic. New approaches in the fight against allergic diseases are called for, the target being the persistence of the atopic T helper 2-skewed immune responder pattern beyond infancy. Atopic dermatitis, the earliest of these conditions, might act as a portal for the development of IgE-mediated atopic manifestations. Abundant evidence implies that specific strains selected from the healthy gut microbiota exhibit powerful antipathogenic and antiinflammatory capabilities, and several targets for the probiotic approach have emerged in atopic dermatitis: degradation/structural modification of enteral antigens, normalization of the properties of aberrant indigenous microbiota and of gut barrier functions, regulation of the secretion of inflammatory mediators, and promotion of the development of the immune system. Better understanding of the effects of different probiotic strains and deeper insight into the mechanisms of the heterogeneous manifestations of atopic disease are needed for the validation of specific strains carrying anti-allergic potential.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
References and Recommended Reading
The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998, 351:1225–1232.
Sibbald B, Rink E, D’Souza M: Is the prevalence of atopy increasing? Br J Gen Pract 1990, 40:338–340.
Nakagawa T, Nakagomi T, Hisamatsu S, et al.: Increased prevalence of elevated serum IgE and IgG4 antibodies in students over a decade. J Allergy Clin Immunol 1996, 97:1165–1166.
Isolauri E, Huurre A, Salminen S, Impivaara O: The allergy epidemic extends beyond the past few decades. Clin Exp Allergy, In press.
Isolauri E, Rautava S, Kalliomäki M, et al.: Role of probiotics in food hypersensitivity. Curr Opin Immunol Clin Allergol 2002, 2:263–271.
Leung DYM, Bieber T: Atopic dermatitis. Lancet 2003, 361:151–160.
Hannifin JM: Atopic dermatitis. J Allergy Clin Immunol 1984, 73:211–222.
Novak N, Bieber T, Leung DYM: Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003, 112:S128-S139. An interesting review that ties together current views on atopic dermatitis and the history behind them.
Novak N, Bieber T: Allergic and nonallergic froms of atopic diseases. J Alergy Clin Immunol 2003, 112:252–262.
Pepys J: "Atopy": a study in definition. Allergy 1994, 49:397–399.
Johansson S, Hourihane J, Bousquet J, et al.: A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001, 56:813–824.
Apter AJ: Early exposure to allergen: Is this the cat’s meow, or are we barking up the wrong tree? J Allergy Clin Immunol 2003, 111:938–946. This excellent review article outlines the cascade of events in the development of atopic diseases and challenges the current thinking of exposure, sensitization, and disease. Useful reading for clinicians to obtain a deeper insight into clinical trials.
Kulig M, Tacke U, Forster J, et al.: Serum IgE levels during the first 6 years of life. J Pediatr 1999, 134:453–458.
Kulig M, Bergmann R, Klettke U, et al.: Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999, 103:1173–1179.
Lau S, Illi S, Sommerfeld C, et al.: Early exposure to housedust mite and cat allergens and development of childhood asthma: a cohort study. Lancet 2000, 356:1392–1397.
Kalliomäki M, Salminen S, Kero P, et al.: Probiotics in the primary prevention of atopic disease: a randomised, placebo-controlled trial. Lancet 2001, 357:1076–1079. This well-controlled study provides the first clinical evidence of probiotic efficacy in the prevention of atopic disease.
Riedler J, Braun-Fahrländer C, Eder W, et al.: Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001, 358:1129–1133. This study documents that human immune function might be programmed by external factors early in life, such as microbial exposure associated with food intake.
Jones CA, Holloway JA, Popplewell EJ, et al.: Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J Allergy Clin Immunol 2002, 109:858–866.
Von Berg A, Koletzko S, Grübl A, et al.: The effect of hydrolyzed cow’s milk formula for allergy prevention in the first year of life: The German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 2003, 111:533–540. An important study that sheds light on the immunomodulatory/ preventive potential of hydrolyzed formulas in allergic disease, including atopic dermatitis.
Bos JD, Kapsenberg ML, Sillevis Smitt JH: Pathogenesis of atopic eczema. Lancet 1994, 343:1338–1341.
Hanifin JM: Atopiform dermatitis: Do we need another confusing name for atopic dermatitis? Br J Dermatol 2002, 147:430–432.
Strachan DP: Hay fever, hygiene, and household size. BMJ 1989, 299:1259–1260.
Yazdanbakhsh M, Kremsner PG, van Ree R: Allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490–494.
Isolauri E: Probiotics in human disease. Am J Clin Nutr 2001, 73:1142S-1146S.
Salminen S, Bouley C, Boutron-Ruault MC, et al.: Gastrointestinal physiology and function—targets for functional food development. Br J Nutr 1998, 80(Suppl):147–171.
Favier C, Vaughan E, de Vos W, Akkermans A: Molecular monitoring of succession of bacterial communities in human neonates. Appl Environm Microbiol 2002, 68:219–226.
Hartmann G, Weiner GJ, Krieg AM: CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 1999, 96:9305–9319.
Neish AS, Gewirtz AT, Zeng H, et al.: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000, 289:1560–1563.
Fukaura H, Kent SC, Pietrusewitz MJ, et al.: Induction of circulating myelin basic protein and proteolipid proteinspecific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996, 98:70–77.
Kalliomäki M, Ouwehand A, Arvilommi H, et al.: Transforming growth factor-beta in breast milk: a potential regulator of atopic disease at an early age. J Allergy Clin Immunol 1999, 104:1251–1257.
Sudo N, Sawamura S, Tanaka K, et al.: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997, 159:1739–1745.
Gr:anlund MM, Arvilommi H, Kero P, et al.: Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0–6 months. Arch Dis Child 2000, 83:F186-F192.
Kalliomäki M, Kirjavainen P, Eerola E, et al.: Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001, 107:129–134.
Björkstén B, Sepp E, Julge K, et al.: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001, 108:516–520.
Isolauri E, Salminen S, Ouwehand AC: Manipulation of the gut microbiota: probiotics. Bailliere’s Best Pract Clin Gastroenterol 2004, 18:299–313.
Majamaa H, Isolauri E: Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997, 99:179–186.
Isolauri E, Arvola T, Sütas Y, et al.: Probiotics in the management of atopic eczema. Clin Exp Allergy 2000, 30:1605–1610.
Rosenfeldt V, Benfeldt E, Dam Nielsen S, et al.: Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003, 111:389–395.
Kalliomäki M, Salminen S, Poussa T, et al.: Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361:1869–1871. This study demonstrates that the preventive potential of specific probiotics in atopic dermatitis is not transient, but might extend beyond infancy.
Rautava S, Kalliomaki M, Isolauri E: Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002, 109:119–121.
About this article
Cite this article
Isolauri, E. Dietary modification of atopic disease: Use of probiotics in the prevention of atopic dermatitis. Curr Allergy Asthma Rep 4, 270–275 (2004). https://doi.org/10.1007/s11882-004-0070-9
- Atopic Dermatitis
- Allergy Clin Immunol
- Intestinal Microbiota
- Probiotic Strain
- Atopic Disease